A Phase III Study of Regional Radiation Therapy in Early Breast Cancer

Radiotherapy to the breast reduces the risk of cancer coming back for women with early breast cancer. This international study will determine if treating a larger area with radiotherapy can further improve the results.

Primary Sponsor

NCIC CTG

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Final Accrual

180

Trial Chairperson

International: Prof Timothy J. Whelan
TROG: A/Prof Boon Chua

Trial Contact

ymurray@ctg.queensu.ca

Clinical Trial Registration

Related Post

14 April, 2026

Consumer Engagement Charter cements TROG’s commitment to listen to consumer voices

LATEST NEWS: 14 April 2026 TROG has made a

9 April, 2026

Vale Professor Jim Denham OAM, TROG founder and world-class researcher

9 April 2026 TROG Cancer Research honours the life